Rotenone
Research stageRecent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Journal of neuroinflammation1
- Microbiome1
- Redox biology1
- Hou L2
- Wang Q2
- Zhang D2
- Zhao J2
- Zhao Z2
- Bao XQ1
- Hong JS1
- Jiang W1
- School of Public Health2
- Affiliated Zhongshan Hospital of Dalian University1
- National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases1
- National-Local Joint Engineering Research Center for Drug-Research and Development (R&D) of Neurodegenerative Diseases1
- Neurobiology Laboratory1
- State Key Laboratory of Bioactive Substrate and Function of Natural Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Rotenone in the shared literature.
Studied across 3 of the same disease areas as Rotenone in the shared literature.
Studied across 2 of the same disease areas as Rotenone in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature